Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Breast cancer patients failing to finish drugs

Half of breast cancer patients fail to finish their prescribed five-year tamoxifen treatment, Scottish research suggests.

Analysis of prescription records of more than 2,000 women also showed one in five regularly forget to take a tablet when a missed tablet every five days increases the risk of dying by 10%.

After one year 10% of women had stopped taking tamoxifen and after two years that figure was 19%, rising to 32% after three and a half years with younger women being more likely to discontinue the treatment.

British Journal of Cancer

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say